Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway

Clinical and Vaccine Immunology

Volumn 17, Issue 3, 2010, Pages 325-334

  Vestrheim, Didrik F ^a   Høiby, E Arne ^a   Aaberge, Ingeborg S ^a   Caugant, Dominique A ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DAY CARE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; NASOPHARYNX; NORWAY; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPING; THROAT CULTURE; VACCINATION;

CARRIER STATE; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; NASAL MUCOSA; NORWAY; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 77649269340     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00435-09     Document Type: Article

References (35)

1. Bogaert, D., R. de Groot, and P. W. Hermans. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4:144-154.
2. Bogaert, D., A. van Belkum, M. Sluijter, A. Luijendijk, R. de Groot, H. C. Rumke, H. A. Verbrugh, and P. W. Hermans. 2004. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363:1871-1872.
3. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Cohen, R., C. Levy, F. de La Rocque, N. Gelbert, A. Wollner, B. Fritzell, E. Bonnet, R. Tetelboum, and E. Varon. 2006. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr. Infect. Dis. J. 25:1001-1007.
5. Dagan, R., M. Sikuler-Cohen, O. Zamir, J. Janco, N. Givon-Lavi, and D. Fraser. 2001. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr. Infect. Dis. J. 20:951-958.
6. Dunais, B., P. Bruno, H. Carsenti-Dellamonica, P. Touboul, P. Dellamonica, and C. Pradier. 2008. Trends in nasopharyngeal carriage of Streptococcus pneumoniae among children attending daycare centers in southeastern France from 1999 to 2006. Pediatr. Infect. Dis. J. 27:1033-1035.
7. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
8. Feil, E. J., B. C. Li, D. M. Aanensen, W. P. Hanage, and B. G. Spratt. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530.
9. Grundmann, H., S. Hori, and G. Tanner. 2001. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J. Clin. Microbiol. 39:4190-4192.
10. Hanage, W. P., S. S. Huang, M. Lipsitch, C. J. Bishop, D. Godoy, S. I. Pelton, R. Goldstein, H. Huot, and J. A. Finkelstein. 2007. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J. Infect. Dis. 195:347-352.
11. Hicks, L. A., L. H. Harrison, B. Flannery, J. L. Hadler, W. Schaffner, A. S. Craig, D. Jackson, A. Thomas, B. Beall, R. Lynfield, A. Reingold, M. Farley, and C. G. Whitney. 2007. Incidence of pneumococcal disease due to nonpneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196:1346-1354.
12. Huang, S. S., J. A. Finkelstein, and M. Lipsitch. 2005. Modeling communityand individual-level effects of child-care center attendance on pneumococcal carriage. Clin. Infect. Dis. 40:1215-1222.
13. Huang, S. S., R. Platt, S. L. Rifas-Shiman, S. I. Pelton, D. Goldmann, and J. A. Finkelstein. 2005. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116:e408-e413.
14. Huang, S. S., V. L. Hinrichsen, A. E. Stevenson, S. L. Rifas-Shiman, K. Kleinman, S. I. Pelton, M. Lipsitch, W. P. Hanage, G. M. Lee, and J. A. Finkelstein. 2009. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 124:e1-e11.
15. Hussain, M., A. Melegaro, R. G. Pebody, R. George, W. J. Edmunds, R. Talukdar, S. A. Martin, A. Efstratiou, and E. Miller. 2005. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol. Infect. 133:891-898.
16. Jolley, K. A., D. J. Wilson, P. Kriz, G. McVean, and M. C. Maiden. 2005. The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol. Biol. Evol. 22:562-569.
17. Kaltoft, M. S., U. B. Skov Sorensen, H. C. Slotved, and H. B. Konradsen. 2008. An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes. J. Microbiol. Methods 75:540-544.
18. Käyhty, H., H. Ahman, K. Eriksson, M. Sorberg, and L. Nilsson. 2005. Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age. Pediatr. Infect. Dis. J. 24:108-114.
19. Kellner, J. D., D. Scheifele, O. G. Vanderkooi, J. Macdonald, D. L. Church, and G. J. Tyrrell. 2008. Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with Streptococcus pneumoniae in children in Calgary, Canada. Pediatr. Infect. Dis. J. 27:526-532.
20. Kyaw, M. H., R. Lynfield, W. Schaffner, A. S. Craig, J. Hadler, A. Reingold, A. R. Thomas, L. H. Harrison, N. M. Bennett, M. M. Farley, R. R. Facklam, J. H. Jorgensen, J. Besser, E. R. Zell, A. Schuchat, C. G. Whitney, and Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drugresistant Streptococcus pneumoniae. N. Engl. J. Med. 354:1455-1463.
21. Lipsitch, M. 1999. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg. Infect. Dis. 5:336-345.
22. Lipsitch, M., K. O'Neill, D. Cordy, B. Bugalter, K. Trzcinski, C. M. Thompson, R. Goldstein, S. Pelton, H. Huot, V. Bouchet, R. Reid, M. Santosham, and K. L. O'Brien. 2007. Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine. J. Infect. Dis. 196:1221-1227.
23. Moore, M. R., R. E. Gertz, Jr., R. L. Woodbury, G. A. Barkocy-Gallagher, W. Schaffner, C. Lexau, K. Gershman, A. Reingold, M. Farley, L. H. Harrison, J. L. Hadler, N. M. Bennett, A. R. Thomas, L. McGee, T. Pilishvili, A. B. Brueggemann, C. G. Whitney, J. H. Jorgensen, and B. Beall. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197:1016-1027.
24. Moore, M. R., T. B. Hyde, T. W. Hennessy, D. J. Parks, A. L. Reasonover, M. Harker-Jones, J. Gove, D. L. Bruden, K. Rudolph, A. Parkinson, J. C. Butler, and A. Schuchat. 2004. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J. Infect. Dis. 190:2031-2038.
25. NORM/NORM-VET. 2007. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. NORM/NORM-VET, Tromsø/Oslo, Norway.
26. O'Brien, K. L., E. V. Millar, E. R. Zell, M. Bronsdon, R. Weatherholtz, R. Reid, J. Becenti, S. Kvamme, C. G. Whitney, and M. Santosham. 2007. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J. Infect. Dis. 196:1211-1220.
27. Park, I. H., D. G. Pritchard, R. Cartee, A. Brandao, M. C. Brandileone, and M. H. Nahm. 2007. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J. Clin. Microbiol. 45:1225-1233.
28. Park, S. Y., M. R. Moore, D. L. Bruden, T. B. Hyde, A. L. Reasonover, M. Harker-Jones, K. M. Rudolph, D. A. Hurlburt, D. J. Parks, A. J. Parkinson, A. Schuchat, and T. W. Hennessy. 2008. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr. Infect. Dis. J. 27:335-340.
29. Regev-Yochay, G., M. Raz, R. Dagan, N. Porat, B. Shainberg, E. Pinco, N. Keller, and E. Rubinstein. 2004. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 38:632-639.
30. Sá-Leão, R., S. Nunes, A. Brito-Avo, C. R. Alves, J. A. Carrico, J. Saldanha, J. S. Almeida, I. Santos-Sanches, and H. De Lencastre. 2008. High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal study. J. Clin. Microbiol. 46:225-234.
31. Simpson, E. H. 1949. Measurement of diversity. Nature 163:688.
32. van Selm, S., L. M. van Cann, M. A. Kolkman, B. A. van der Zeijst, and J. P. van Putten. 2003. Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect. Immun. 71:6192-6198.
33. Vestrheim, D. F., E. A. Hoiby, I. S. Aaberge, and D. A. Caugant. 2008. Phenotypic and genotypic characterization of Streptococcus pneumoniae strains colonizing children attending day-care centers in Norway. J. Clin. Microbiol. 46:2508-2518.
34. Vestrheim, D. F., O. Lovoll, I. S. Aaberge, D. A. Caugant, E. A. Hoiby, H. Bakke, and M. R. Bergsaker. 2008. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 26:3277-3281.
35. World Health Organization. 2007. Pneumococcal conjugate vaccine for childhood immunization. WHO position paper. Wkly. Epidemiol. Rec. 82:93-104.